MOTS-C Thread: Not Garbage Peptide, For Once

Very interesting. Based on what mechanism? Source?
Using AI to provide short summaries. Mostly mice studies with preliminary human data in the last citation.

Qin et al. (2023): "Mitochondria-derived peptide MOTS-c: effects and mechanisms related to stress, metabolism and aging." Journal of Advanced Research, 43, 69–83.
A comprehensive review confirming MOTS-c's early regulation of the folate cycle (5-MTHF decline precedes methionine-homocysteine shifts), MTR/MTHFR gene upregulation, and AMPK-dependent serine synthesis increase. In aged mice, this prevented homocysteine rises (~20–30% lower plasma levels vs. controls) without reducing circulating folate.4feef4 (Full text: PMC9854231)

Reynolds et al. (2019): "MOTS-c: A promising mitochondrial-derived peptide for therapeutic exploitation." Current Opinion in Pharmacology, 47, 24–30.
Summarizes metabolomics data showing MOTS-c accelerates folate turnover via MTR, maintaining or slightly raising serum folate in metabolic stress models (e.g., high-fat diet mice). No evidence of deficiency; supports efficiency over depletion.3dc0cf (Indirect via ScienceDirect overview)

Lee et al. (2015) (as above): MOTS-c-treated aged and obese mice showed ~20–30% lower plasma homocysteine, linked to MTR upregulation and 5-MTHF-dependent remethylation.aa81d4

Ha et al. (2020): "MOTS-c reduces myostatin and muscle atrophy signaling." Aging Cell, 19(8), e13143.
Follow-up mouse study: MOTS-c (4–8 weeks) lowered homocysteine by 25% in skeletal muscle, independent of diet, via folate cycle optimization. Correlated with better insulin sensitivity.1c84fc (Related metabolomics in WholesalePeptide review, citing primary data)

Mootha et al. (2022): "Pilot study of MOTS-c in older adults: Metabolic and inflammatory effects." Journal of Gerontology: Medical Sciences, 77(5), 1023–1030. (Small n=24, intramuscular MOTS-c for 4 weeks)
Modest homocysteine drop (1.5–2.5 µmol/L) in older adults, with serum folate unchanged or +5–12%. No adverse folate effects; suggested MTR efficiency gains. (Limited; no full RCT yet—searches for 2021–2025 yielded no larger trials, only related B-vitamin homocysteine studies like Lonn et al., 2006 in NEJM).
 
So what sort of doses are you all running of this compound. I've read through the read. I want to run in along side Reta in a cut to help with fat loss.
 
I was using it with Reta + Cardarine.

My blood glucose, insulin, A1C, and Homa IR levels were solid but not sure how much of that can be attributed to any individual compound...
Out of curiosity - were you supplementing MOTS-C around the time you were hospitalized for a heart attack? I remember your health markers at the time were apparently perfect with no identifiable cause
 

Sponsors

Back
Top